Day: June 13, 2021

Dry Construction Market to Cross USD 102.8 Billion by 2027 | Market Research Future (MRFR)

Dry Construction Market to Cross USD 102.8 Billion by 2027 | Market Research Future (MRFR)

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key companies profiled are Saint-Gobain (France), Etex (Belgium), Xella Group (Germany), Radman’s Building Services (Croatia), Georgia-Pacific (US), Knauf Gips KG (Germany), USG Boral (Singapore), Beijing New Building Materials Public Limited Company (China), Dry Construction Limited (UK), Winstone Wallboards Limited (New Zealand), SIAMATRAS (Greece), PABCO Gypsum (US), and AWI Licensing LLC (Pennsylvania), among others. Pune, June 14, 2021 (GLOBE NEWSWIRE) — Global Dry Construction Market was valued at USD 79.7 billion in 2019, and it is expected to reach USD 102.8 billion by 2027 at 5.1% CAGR during the forecast period (2020 – 2027). The dry construction market outlook looks extremely promising. Factors such as the increase in the popularity of dry concrete in recent years and expansion in the construction sector...

Continue reading

Terns Pharmaceuticals to Host Conference Call to Discuss Top-line Results from Phase 2a LIFT Study of TERN-101 for Treatment of NASH

Terns Pharmaceuticals to Host Conference Call to Discuss Top-line Results from Phase 2a LIFT Study of TERN-101 for Treatment of NASH

Written by Customer Service on . Posted in Public Companies.

FOSTER CITY, Calif., June 13, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases, announced that the Company will host a conference call and live webcast on Monday, June 14, 2021 at 8:30 a.m. ET (5:30 a.m. PT) to discuss new top-line data from the Phase 2a LIFT study evaluating TERN-101 in patients with NASH. Webcast and conference call details are as follows: Webcast link: https://edge.media-server.com/mmc/p/2gsxxmta Live Conference CallDomestic Callers (U.S./Canada toll-free): (833) 665-0612International Callers: (929) 517-0403Conference ID: 7587739 Following the...

Continue reading

Finning hosts investor day and provides growth outlook

Finning hosts investor day and provides growth outlook

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, June 13, 2021 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”, “the Company”, “we”, “our” or “us”) is hosting a virtual Investor Day on June 14 starting at 11:00 AM Eastern Time. Following the presentations by members of our leadership team, participants will have an opportunity to ask questions using the webcast portal. “We continue to execute on our Global Strategic Priorities designed to improve our return on invested capital performance and ultimately increase our earnings capacity. Robust execution through 2020 put us back on track to achieve strong ROIC in line with our 2018 investor day objectives, albeit one year later. Significant ROIC improvements in all three regions will be increasingly evident starting with our Q2 2021 results, as improved market activity that we had...

Continue reading

RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis

RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis

Written by Customer Service on . Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., June 13, 2021 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that the Company plans to report top line data from its Phase 1b clinical trial of RPT193 in patients with moderate to severe atopic dermatitis (AD) in a premarket press release and webcast on Monday, June 14, 2021. RAPT will host a conference call accompanied by a slide presentation at 8:30 a.m. ET on Monday, June 14th. The live webcast and audio archive of the presentation may be accessed on the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations. The call can...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.